Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–5 of 5 results
Advanced filters: Author: "Michael J. Bevan" Clear advanced filters
  • A drug that normally suppresses an immune response by trapping lymphocytes in lymphoid organs results in the elimination of a chronic viral infection when applied at low doses. Why should this be?

    • Michael J. Bevan
    • Pamela J. Fink
    News & Views
    Nature
    Volume: 454, P: 837-838
  • Two therapeutic drugs have been found to enhance memory in immune cells called T cells, apparently by altering cellular metabolism. Are changes in T-cell metabolism the key to generating long-lived immune memory?

    • Martin Prlic
    • Michael J. Bevan
    News & Views
    Nature
    Volume: 460, P: 41-42
  • Here, John Harty and Vladimir Badovinac describe the factors that control the generation of memory CD8+ T cells, discuss how these factors can characterize this response and highlight how the manipulation of these factors could reshape CD8+T-cell memory.

    • John T. Harty
    • Vladimir P. Badovinac
    Reviews
    Nature Reviews Immunology
    Volume: 8, P: 107-119
  • Microorganism- and host-derived signals can stimulate formation of a multiprotein complex called the inflammasome, which activates the cysteine protease caspase 1. In turn, caspase 1 triggers an inflammatory programmed cell death pathway known as pyroptosis. Numerous pathogens have evolved a mechanism to subvert pyroptosis and persist within infected cells.

    • Tessa Bergsbaken
    • Susan L. Fink
    • Brad T. Cookson
    Reviews
    Nature Reviews Microbiology
    Volume: 7, P: 99-109